Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Calgary
Clinical trial register · Canada

Clinical Trials in Calgary, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6533 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:20 UTC
6533
Studies in scope
all four open statuses
3514
Recruiting now
open to new participants
886
Lead sponsors
across recruiting studies
Top sites
Hamilton 16 Calgary 16 Toronto 13 Vancouver 13 Halifax 12
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Calgary149 AstraZeneca61 AbbVie36 Janssen Research & Development, LLC30 National Cancer Institute (NCI)26 Clear sponsor filter
Site location
Hamilton16 Calgary16 Toronto13 Vancouver13 Halifax12
All 51 locations
Target enrolment
to

Trials with a site in Calgary

16 of 6533 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
Novo Nordisk A/S
Phase 3
1,778
Calgary, Edmonton, Red Deer, Kelowna, Sydney, Sarnia, Stouffville, Toronto
2026-08-24
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Calgary, Kelowna, Surrey, Victoria, Moncton, Halifax, Sydney, Brampton
2026-05-21
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Calgary, Vancouver, Winnipeg, Moncton, Halifax, Burlington, Courtice, Hamilton
2026-05-11
Recruiting
Novo Nordisk A/S
Phase 3
400
Calgary, Guelph, Hamilton, Trois-Rivières, Québec
2026-04-13
Recruiting
Novo Nordisk A/S
Phase 3
1,150
Calgary, Surrey, Moncton, Halifax, London
2026-02-24
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Calgary, Vancouver, Québec, Halifax, Greater Sudbury, Hamilton, London, Mississauga
2025-10-02
Recruiting
Novo Nordisk A/S
Phase 4
586
Calgary, Edmonton, New Westminster, Winnipeg, Moncton, Brampton, Burlington, Concord
2025-08-15
Active, closed
Novo Nordisk A/S
Phase 3
877
Calgary, Vancouver, Winnipeg, Halifax, Brampton, Etobicoke, Hamilton, London
2025-08-11
Recruiting
Novo Nordisk A/S
Phase 3
510
Calgary, Edmonton, Vancouver, London, Scarborough Village, Toronto, Montreal
2025-02-17
Active, closed
Novo Nordisk A/S
Phase 4
500
Calgary, Edmonton, Vancouver, Markham, Toronto, West Hamilton, Montreal
2024-09-17
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Calgary, Edmonton, Kelowna, Vancouver, Winnipeg, Saint John, Halifax, Barrie
2024-06-25
Active, closed
Novo Nordisk A/S
Phase 3
673
Calgary, Cambridge, Scarborough Village, Toronto, Waterloo, Montreal, Québec
2024-04-01
Active, closed
Novo Nordisk A/S
Phase 2
88
Calgary, Vancouver
2024-02-20
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Calgary, Moncton, Halifax, Barrie, Brampton, Cambridge, Hamilton, Toronto
2023-03-01
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Calgary, Vancouver, Halifax, Brampton, London, Toronto, Vaughan, Chicoutimi
2021-04-01
By invitation
Novo Nordisk A/S
Observational
60
Calgary, Edmonton, Winnipeg, St. John's, Hamilton, Toronto
2019-04-01
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-canada/city/calgary

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,533 studies in total at the last sync on 11 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies with a site in Calgary that also match the filters currently applied.

How many clinical trials are recruiting in Calgary?

8 of the 16 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Calgary), 16 studies
PhaseStudiesRecruitingShare
Phase 312775%
Phase 42112.5%
Observational106.3%
Phase 2106.3%

Most active sponsors

Lead sponsors with the most studies (Calgary)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S168
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.